The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects
About the Authors
Paul Kind
University of York
United Kingdom
United Kingdom
Jennifer Elston Lafata
Center for Health Service Research, Henry Ford Health System
United States
United States
Karl Matuszewski
University HealthSystem Consortium
United States
United States
Dennis Raisch
University of New Mexico
United States
United States
I. A. Vilum
First Pavlov State Medical University of St. Peterburg; National Medical and Surgical Center of the N.I. Pirogov
Russian Federation
Russian Federation
ассистент,
Санкт-Петербург
A. S. Kolbin
First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russia; Saint Petersburg State University, Saint Petersburg, Russia
Russian Federation
Russian Federation
д.м.н., профессор,
Санкт-Петербург
References
1. American College of Physicians. Information on cost- effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;148:956-61.
2. Aspinall S.L., Good C.B., Glassman P.A., Valentino M.A. The evolv- ing use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs. Med Care 2005;43: 20-6.
3. Parameswaran R., McNair A., Avery K.N., et al. The role of health- related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 2008;15:2372-9.
4. Halyard M.Y., Ferrans C.E. Quality-of-life assessment for routine oncology clinical practice. J Support Oncol 2008;6:221-33.
5. Alishiri G.H., Bayat N., Fathi Ashtiani A., et al. Logistic regres- sion models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Mod Rheumatol in press.
6. Kolotkin R.L., Crosby R.D., Gress R.E., et al. Health and health-related quality of life: differences between men and women who seek gastric bypass surgery. Surg Obes Relat Dis 2008;4: 651-8.
7. Efficace F., Kemmler G., Vignetti M., et al. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials-a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008;44: 1497-506.
8. Weinfurt KP. Outcomes research related to patient decision making in oncology. Clin Ther 2003;25:671-83.
9. Kaplan R.M. Shared medical decision-making: a new paradigm for behavioral medicine-1997 presidential address. Ann Behav Med 1999;21:3-11.
10. Eiser C., Darlington A.S., Stride C.B., Grimer R. Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma 2001;5:189-95.
11. de Haes H, Koedoot N. Patient centered decision making in palliative cancer treatment: a world of paradoxes. Patient Educ Couns 2003;50:43-9.
12. Solomon M.J., Pager C.K., Keshava A., et al. What do patients want? Patient preferences and surrogate decision making in the treat- ment of colorectal cancer. Dis Colon Rectum 2003;46: 1351-7.
13. Protiere C., Viens P., Genre D., et al. Patient participation in medical decision-making: a French study in adjuvant radio- chemotherapy for early breast cancer. Ann Oncol 2000;11:39- 45.
14. Schackman B.R., Teixeira P.A., Weitzman G., et al. Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree? Med Decis Making 2008;28:233-42.
15. Goodlin S.J., Quill T.E., Arnold R.M. Communication and decision- making about prognosis in heart failure care. J Card Fail 2008;14:106-13.
16. Pruchno R.A., Lemay E.P. Jr, Field L., Levinsky N.G. Predictors of patient treatment preferences and spouse substituted judgments: the case of dialysis continuation. Med Decis Making 2006;26: 112-21.
17. Grosset K.A., Grosset D.G. Patient-perceived involvement and sat- isfaction in Parkinson’s disease: effect on therapy decisions and quality of life. Mov Disord 2005;20:616-9.
18. Hankins J., Hinds P., Day S., et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer 2007;48:705-10.
19. Sullivan M.D., Levy W.C., Russo J.E., et al. Summary health status measures in advanced heart failure: relationship to clinical vari- ables and outcome. J Card Fail 2007;13:560-8.
20. Glasziou P., Alexander J., Beller E., Clarke P. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes 2007;5:21.
21. Watkins J.B., Minshall M.E., Sullivan S.D. Application of economic analyses in U.S. managed care formulary decisions: a private payer’s experience. J Manag Care Pharm 2006;12:726-35.
22. Schmittdiel J., Vijan S., Fireman B., et al. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care 2007;45:315-21.
23. Department of Health. Guidance on the routine collection of Patient Reported Outcome Measures (PROMs). Available from: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_091451 [Accessed Decem- ber 12, 2008].
24. Prochaska J.M., Prochaska J.O., Levesque D.A. A transtheoretical approach to changing organizations. Adm Policy Ment Health 2001;28:247-61.
25. Prochaska J.O., Velicer W.F. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38-48.
26. Levesque D.A., Cummins C.O., Prochaska J.M., Prochaska J.O. Stage of change for making an informed decision about medicare health plans. Health Serv Res 2006;41:1372-91.
Review
For citations:
Kind P., Lafata J.E., Matuszewski K., Raisch D., Vilum I.A., Kolbin A.S. The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2015;(2):92-97. (In Russ.)
Views:
2466
Email this article 